Literature DB >> 8477881

Both acute and chronic near-normoglycaemia are required to improve insulin resistance in type 1 (insulin-dependent) diabetes mellitus.

P Fasching1, K Ratheiser, P Damjancic, B Schneider, P Nowotny, H Vierhapper, W Waldhäusl.   

Abstract

To determine the impact of both short- and long-term "near-normoglycaemia" on insulin resistance in Type 1 (insulin-dependent) diabetes hepatic glucose production (mg.kg-1.min-1) and peripheral glucose utilisation ("M-value", mg.kg-1.min-1) were estimated during an euglycaemic hyperinsulinaemic clamp (10 mU.kg.min) in patients with either good (HbA1c < 5.8%, groups A and B) or poor (HbA1c > 7.5%, groups C and D) long-term metabolic control (time > 12 months) and in healthy subjects (HbA1c: 5.08 +/- 0.20%; n = 8). To this end blood glucose was stabilized at 6.7 mmol/l by overnight (t = 12 h) i.v. regular insulin in groups (n = 8 each) A (HbA1c: 5.49 +/- 0.46%) and C (HbA1c: 8.83 +/- 1.20%), while groups B (HbA1c: 5.55 +/- 0.19%) and D (HbA1c: 8.51 +/- 1.09%) were kept overnight on long-acting insulin without feed-back control of blood glucose before euglycaemic clamping. Thereby, pre-equilibration of blood glucose at 6.7 mmol/l was shown to normalize basal hepatic glucose production (A: 2.27 +/- 0.48; C 2.50 +/- 0.57 mg.kg-1.min-1) despite different HbA1c values, whereas basal hepatic glucose production stayed elevated in groups B (3.09 +/- 0.38 mg.kg-1.min-1) and D (3.21 +/- 0.58 mg.kg-1.min-1) with poor actual glycaemia (B: 10.9 +/- 4.6; D: 12.1 +/- 4.6 mmol/l).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8477881     DOI: 10.1007/bf00400239

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  35 in total

Review 1.  The physiological basis of insulin treatment--clinical aspects.

Authors:  W K Waldhäusl
Journal:  Diabetologia       Date:  1986-12       Impact factor: 10.122

2.  Improved in vivo insulin effect during continuous subcutaneous insulin infusion in patients with IDDM.

Authors:  H Beck-Nielsen; B Richelsen; C Hasling; O H Nielsen; L Heding; N S Sørensen
Journal:  Diabetes       Date:  1984-09       Impact factor: 9.461

3.  Enhanced hepatic insulin sensitivity, but peripheral insulin resistance in patients with type 1 (insulin-dependent) diabetes.

Authors:  O Hother-Nielsen; O Schmitz; J Bak; H Beck-Nielsen
Journal:  Diabetologia       Date:  1987-11       Impact factor: 10.122

Review 4.  Acute and chronic effects of hyperglycaemia on glucose metabolism.

Authors:  H Yki-Järvinen
Journal:  Diabetologia       Date:  1990-10       Impact factor: 10.122

5.  Comparison of insulin-mediated and glucose-mediated glucose disposal in patients with insulin-dependent diabetes mellitus and in nondiabetic subjects.

Authors:  I L Hansen; P E Cryer; R A Rizza
Journal:  Diabetes       Date:  1985-08       Impact factor: 9.461

6.  Insulin production rate following glucose ingestion estimated by splanchnic C-peptide output in normal man.

Authors:  W Waldhäusl; P Bratusch-Marrain; S Gasic; A Korn; P Nowotny
Journal:  Diabetologia       Date:  1979-10       Impact factor: 10.122

7.  Reversal of insulin resistance in type I diabetes after treatment with continuous subcutaneous insulin infusion.

Authors:  I Lager; P Lönnroth; H von Schenck; U Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-03

8.  Insulin action is normalized in newly diagnosed type I diabetic patients after three months of insulin treatment.

Authors:  H G Nijs; J K Radder; M Frölich; H M Krans
Journal:  Metabolism       Date:  1988-05       Impact factor: 8.694

9.  Hyperglycemia decreases glucose uptake in type I diabetes.

Authors:  H Yki-Järvinen; E Helve; V A Koivisto
Journal:  Diabetes       Date:  1987-08       Impact factor: 9.461

10.  The contribution of hyperglycaemia and hypoinsulinaemia to the insulin resistance of streptozotocin-diabetic rats.

Authors:  G Lisato; I Cusin; A Tiengo; S Del Prato; B Jeanrenaud
Journal:  Diabetologia       Date:  1992-04       Impact factor: 10.122

View more
  4 in total

1.  Features of hepatic and skeletal muscle insulin resistance unique to type 1 diabetes.

Authors:  Bryan C Bergman; David Howard; Irene E Schauer; David M Maahs; Janet K Snell-Bergeon; Robert H Eckel; Leigh Perreault; Marian Rewers
Journal:  J Clin Endocrinol Metab       Date:  2012-02-22       Impact factor: 5.958

2.  Postprandial and fasting hepatic glucose fluxes in long-standing type 1 diabetes.

Authors:  Michaela Kacerovsky; John Jones; Albrecht I Schmid; Cristina Barosa; Angelika Lettner; Gertrud Kacerovsky-Bielesz; Julia Szendroedi; Marek Chmelik; Peter Nowotny; Visvanathan Chandramouli; Michael Wolzt; Michael Roden
Journal:  Diabetes       Date:  2011-05-11       Impact factor: 9.461

3.  Chronic peripheral hyperinsulinemia in type 1 diabetic patients after successful combined pancreas-kidney transplantation does not affect ectopic lipid accumulation in skeletal muscle and liver.

Authors:  Marietta Stadler; Christian Anderwald; Giovanni Pacini; Stefan Zbýn; Miriam Promintzer-Schifferl; Martina Mandl; Martin Bischof; Stephan Gruber; Peter Nowotny; Anton Luger; Rudolf Prager; Michael Krebs
Journal:  Diabetes       Date:  2009-10-15       Impact factor: 9.461

4.  Intentional overdose with insulin: prognostic factors and toxicokinetic/toxicodynamic profiles.

Authors:  Bruno Mégarbane; Nicolas Deye; Vanessa Bloch; Romain Sonneville; Corinne Collet; Jean-Marie Launay; Frédéric J Baud
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.